© Springer International Publishing Switzerland 2016
Antonio M. Esquinas (ed.)Noninvasive Mechanical Ventilation10.1007/978-3-319-21653-9_3939. Noninvasive Mechanical Ventilation in Duchenne Muscular Dystrophy: What Have We Learned?
(1)
Division of Respiratory Physiopathology and Rehabilitation, A.O.R.N. “Dei Colli” – Monaldi Hospital, Naples, Italy
(2)
Cardiac Anesthesia and Intensive Care Unit, A.O.R.N. “Dei Colli” – Monaldi Hospital, Naples, Italy
Keywords
Duchenne muscular dystrophyRespiratory failureRespiratory muscle weaknessNoninvasive mechanical ventilationAbbreviations
DMD
Duchenne muscular dystrophy
FVC
Forced vital capacity
IPAP
Inspiratory positive airway pressures
PaCO2
Arterial partial pressure of CO2
REM
Rapid eye movement
RR
Respiratory rate
SDB
Sleep disordered breathing
VC
Vital capacity
VT
Tidal volume
39.1 Introduction
Pulmonary complications in Duchenne muscular dystrophy (DMD) are usually more predictable than in other neuromuscular diseases because they correlate with overall muscle strength. Respiratory failure in DMD is primarily associated with restrictive pulmonary disease caused by inspiratory muscle weakness, severe scoliosis, reduced lung and chest wall compliance, and ineffective cough because of respiratory muscle weakness. The majority of patients also develop cardiomyopathy. Respiratory disease is a nearly inevitable complication in adult DMD patients, and it represents the underlying cause of death in 70 % of DMD patients younger than 25 years [1].
39.2 Discussion and Analysis
39.2.1 Diurnal and Nocturnal Respiratory Function in DMD
Because, in healthy subjects, vital capacity (VC) increases with growth during the first decade of life, early respiratory muscle dysfunction may be masked until VC does not reach its plateau. Accordingly, in DMD patients, VC progressively decreases by about 5–6 % per year, usually starting around 12 years of age. However, the rate of this decline may be variable: in particular, a sudden reduction in VC can be occasionally precipitated by intercurrent events such as a worsening of scoliosis or infective complications leading to the development of hypoventilation. A forced vital capacity (FVC) ≤1 l is a predictor of poor outcome, with a survival rate at 5 years of only 8 % if assisted ventilation is not provided [2].
Reductions in maximum inspiratory pressure occur early in the clinical course of DMD and may precede the reduction in VC. However, despite significant weakness of the respiratory muscles, pulmonary symptoms are often minimal in the early stages of the disease. Particularly, hypercapnia is uncommon in patients with DMD in the absence of pulmonary infections. This is believed to be due to a relative preservation of diaphragm function until the later stages of the disease. Anyhow, once hypercapnia develops, the course is rapidly progressive [1].